172 related articles for article (PubMed ID: 12428248)
1. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy.
Wang X; Kuivaniemi H; Bonavita G; Mutkus L; Mau U; Blau E; Inohara N; Nunez G; Tromp G; Williams CJ
Arthritis Rheum; 2002 Nov; 46(11):3041-5. PubMed ID: 12428248
[TBL] [Abstract][Full Text] [Related]
2. Blau arteritis resembling Takayasu disease with a novel NOD2 mutation.
Khubchandani RP; Hasija R; Touitou I; Khemani C; Wouters CH; Rose CD
J Rheumatol; 2012 Sep; 39(9):1888-92. PubMed ID: 22859352
[TBL] [Abstract][Full Text] [Related]
3. NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis.
Newman B; Rubin LA; Siminovitch KA
J Rheumatol; 2003 Feb; 30(2):305-7. PubMed ID: 12563685
[TBL] [Abstract][Full Text] [Related]
4. CARD15 mutations in Blau syndrome.
Miceli-Richard C; Lesage S; Rybojad M; Prieur AM; Manouvrier-Hanu S; Häfner R; Chamaillard M; Zouali H; Thomas G; Hugot JP
Nat Genet; 2001 Sep; 29(1):19-20. PubMed ID: 11528384
[TBL] [Abstract][Full Text] [Related]
5. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis.
Rosé CD; Doyle TM; McIlvain-Simpson G; Coffman JE; Rosenbaum JT; Davey MP; Martin TM
J Rheumatol; 2005 Feb; 32(2):373-5. PubMed ID: 15693102
[TBL] [Abstract][Full Text] [Related]
6. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
[TBL] [Abstract][Full Text] [Related]
7. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
Aróstegui JI; Arnal C; Merino R; Modesto C; Antonia Carballo M; Moreno P; García-Consuegra J; Naranjo A; Ramos E; de Paz P; Rius J; Plaza S; Yagüe J
Arthritis Rheum; 2007 Nov; 56(11):3805-13. PubMed ID: 17968944
[TBL] [Abstract][Full Text] [Related]
8. Blau syndrome associated with a CARD15/NOD2 mutation.
Snyers B; Dahan K
Am J Ophthalmol; 2006 Dec; 142(6):1089-92. PubMed ID: 17157607
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review.
Punzi L; Furlan A; Podswiadek M; Gava A; Valente M; De Marchi M; Peserico A
Autoimmun Rev; 2009 Jan; 8(3):228-32. PubMed ID: 18718560
[TBL] [Abstract][Full Text] [Related]
10. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation.
Kurokawa T; Kikuchi T; Ohta K; Imai H; Yoshimura N
Ophthalmology; 2003 Oct; 110(10):2040-4. PubMed ID: 14522785
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members.
Milman N; Ursin K; Rødevand E; Nielsen FC; Hansen TV
Scand J Rheumatol; 2009; 38(3):190-7. PubMed ID: 19169908
[TBL] [Abstract][Full Text] [Related]
12. [Blau syndrome--a chronic granulomatous, genetic disease].
Milman N; Byg KE
Ugeskr Laeger; 2006 Oct; 168(42):3612-4. PubMed ID: 17069723
[TBL] [Abstract][Full Text] [Related]
13. Bupropion for Blau syndrome.
Altschuler EL; Kast RE
Med Hypotheses; 2004; 62(2):297-8. PubMed ID: 14962643
[TBL] [Abstract][Full Text] [Related]
14. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
[TBL] [Abstract][Full Text] [Related]
15. Familial case of Blau syndrome associated with a CARD15/NOD2 mutation.
Villanueva-Mendoza C; Arellanes-García L; Cubas-Lorenzo V; Jimenez-Martinez MC; Flores-Suárez LF; Zenteno JC
Ophthalmic Genet; 2010 Sep; 31(3):155-8. PubMed ID: 20565245
[TBL] [Abstract][Full Text] [Related]
16. Blau syndrome-associated mutations in exon 4 of the caspase activating recruitment domain 15 (CARD 15) gene are not found in ethnic Danes with sarcoidosis.
Milman N; Nielsen FC; Hviid TV; Hansen Tv
Clin Respir J; 2007 Dec; 1(2):74-9. PubMed ID: 20298285
[TBL] [Abstract][Full Text] [Related]
17. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
[TBL] [Abstract][Full Text] [Related]
18. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease.
Tomer G; Ceballos C; Concepcion E; Benkov KJ
Am J Gastroenterol; 2003 Nov; 98(11):2479-84. PubMed ID: 14638352
[TBL] [Abstract][Full Text] [Related]
19. Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation.
Milman N; Andersen CB; Hansen A; van Overeem Hansen T; Nielsen FC; Fledelius H; Ahrens P; Nielsen OH
APMIS; 2006 Dec; 114(12):912-9. PubMed ID: 17207093
[TBL] [Abstract][Full Text] [Related]
20. Blau syndrome.
Latkany P
Ophthalmology; 2004 Apr; 111(4):853; author reply 853-4. PubMed ID: 15051234
[No Abstract] [Full Text] [Related]
[Next] [New Search]
